LKFT

Lakefront Biotherapeutics NV

Price Chart

No historical data available

Latest Quote

$29.16

-0.54 (-1.82%)

Current Price

Previous Close	$29.70
Open	$29.55
Day High	$29.55
Day Low	$29.14
Volume	172,513

Fetched: 2026-08-27T07:52:25

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	65.48M
Total Debt	$7.37M
Cash Equivalents	$2.60B
Revenue	$1.15B
Net Income	$688.67M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$1.89B
P/E Ratio	2.74
EPS (TTM)	$10.53
Exchange	NMS

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

📰 Latest News

No news articles available at the moment. Check back later for updates on LKFT.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$34,726,147	$2,961,579	$0	$0
Cost Of Revenue	$34,726,147	$40,713,534	$0	$0
Total Revenue	$1,298,899,898	$321,907,037	$279,953,283	$281,734,201
Operating Revenue	$1,298,899,898	$321,907,037	$279,953,283	$281,734,201
Expenses
Interest Expense	$2,589,046	$1,063,879	$2,067,033	$10,691,346
Total Expenses	$713,367,967	$541,850,978	$383,028,138	$434,784,531
Other Income Expense	$-286,941,488	$111,870,838	$18,979,329	$60,141,305
Net Non Operating Interest Income Expense	$52,771,224	$104,470,394	$90,664,485	$10,170,501
Total Other Finance Cost	$-1,244,891	$-696,018	$235,899	$268,597
Interest Expense Non Operating	$2,589,046	$1,063,879	$2,067,033	$10,691,346
Operating Expense	$678,641,821	$501,137,444	$383,028,138	$434,784,531
Other Operating Expenses	$296,625	$-19,136,984	$-27,618,825	$-10,964,615
Selling And Marketing Expense	$1,625,598	$3,285,064	$2,074,039	$1,479,622
General And Administrative Expense	$129,122,969	$109,852,854	$107,994,860	$119,167,346
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$373,107,550	$-1,497,139	$-4,657,246	$-83,406,515
Net Interest Income	$52,771,224	$104,470,394	$90,664,485	$10,170,501
Interest Income	$54,115,379	$104,838,256	$92,967,417	$21,130,445
Normalized Income	$599,791,326	$-89,875,101	$-19,650,916	$-130,918,146
Net Income From Continuing And Discontinued Operation	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Total Operating Income As Reported	$344,550,970	$-219,943,941	$-103,074,855	$-153,049,163
Net Income Common Stockholders	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Net Income	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Net Income Including Noncontrolling Interests	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Net Income Discontinuous Operations	$1,625,598	$88,011,210	$251,880,178	$-171,166,645
Net Income Continuous Operations	$373,107,550	$-1,497,139	$-4,657,246	$-83,406,515
Pretax Income	$351,361,667	$-3,602,709	$6,568,959	$-82,738,525
Special Income Charges	$-240,980,961	-	-	-
Interest Income Non Operating	$54,115,379	$104,838,256	$92,967,417	$21,130,445
Operating Income	$585,531,931	$-219,943,941	$-103,074,855	$-153,050,330
Depreciation Amortization Depletion Income Statement	$11,077,893	$15,382,459	$18,791,311	$10,029,195
Depreciation And Amortization In Income Statement	$11,077,893	$15,382,459	$18,791,311	$10,029,195
Depreciation Income Statement	$11,077,893	$15,382,459	$18,791,311	$10,029,195
Gross Profit	$1,264,173,751	$281,193,503	$279,953,283	$281,734,201
Per Share
Diluted EPS	$5.69	$1.31	$3.75	$-3.88
Basic EPS	$5.69	$1.31	$3.75	$-3.88
Other
Tax Effect Of Unusual Items	$-60,257,712	$23,492,876	$3,985,659	$12,629,674
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$706,143,864	$-61,275,253	$40,622,445	$-55,619,525
Total Unusual Items	$-286,941,488	$111,870,838	$18,979,329	$60,141,305
Total Unusual Items Excluding Goodwill	$-286,941,488	$111,870,838	$18,979,329	$60,141,305
Reconciled Depreciation	$65,251,663	$53,134,415	$50,965,782	$76,568,958
EBITDA (Bullshit earnings)	$419,202,376	$50,595,585	$59,601,774	$4,521,780
EBIT	$353,950,713	$-2,538,830	$8,635,992	$-72,047,179
Diluted Average Shares	$76,955,505	$77,244,706	$76,940,323	$76,678,663
Basic Average Shares	$76,955,505	$77,244,706	$76,940,323	$76,678,663
Diluted NI Availto Com Stockholders	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Tax Provision	$-21,745,883	$-2,105,570	$11,226,206	$667,990
Impairment Of Capital Assets	$266,392,615	-	-	-
Restructuring And Mergern Acquisition	$-25,411,654	-	-	-
Gain On Sale Of Security	$-45,960,527	$111,870,838	$18,979,329	$60,141,305
Research And Development	$536,518,735	$391,754,052	$281,786,753	$315,072,984
Selling General And Administration	$130,748,567	$113,137,917	$110,068,899	$120,646,968
Other Gand A	$34,540,464	$40,714,702	$27,304,683	$27,810,346
Salaries And Wages	$94,582,505	$69,138,151	$80,690,177	$91,357,000

Fetched: 2026-08-23

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$3,777,904,881	$3,108,801,774	$3,034,103,655	$2,697,489,156
Total Assets	$3,978,182,818	$4,829,754,684	$5,088,632,410	$5,528,846,113
Total Non Current Assets	$381,946,742	$929,894,882	$579,010,852	$580,989,130
Other Non Current Assets	$3,456,732	$3,796,567	$6,832,886	$6,747,635
Non Current Prepaid Assets	$0	$6,372,766	$11,933,901	$0
Non Current Deferred Assets	$227,724	$1,721,359	$1,314,960	$1,591,732
Non Current Deferred Taxes Assets	$227,724	$1,721,359	$1,314,960	$1,591,732
Non Current Note Receivables	$24,728,483	$0	-	-
Non Current Accounts Receivable	$203,680,950	$204,594,181	$164,956,204	$140,068,899
Investmentin Financial Assets	$0	$233,775,542	$0	$0
Goodwill And Other Intangible Assets	$990,307	$274,287,045	$230,600,253	$252,441,897
Other Intangible Assets	$990,307	$192,528,317	$149,370,545	$170,913,229
Current Assets	$3,596,236,076	$3,899,859,802	$4,509,621,558	$4,947,856,983
Assets Held For Sale Current	$0	$12,980,264	$25,791,194	$0
Current Deferred Assets	$6,551,442	$35,284,362	$17,087,469	$14,047,647
Restricted Cash	$0	$48,070,769	$0	-
Prepaid Assets	$120,285	$120,285	$861,847	$569,894
Inventory	$26,267,663	$59,782,785	$86,392,618	$61,806,609
Receivables	$62,131,261	$102,872,823	$76,672,894	$90,323,483
Other Receivables	$50,957,608	$64,952,702	$56,243,138	$57,398,107
Accounts Receivable	$11,173,654	$37,920,121	$20,429,756	$32,925,376
Cash Cash Equivalents And Short Term Investments	$3,501,165,425	$3,640,748,513	$4,302,815,535	$4,781,107,015
Cash And Cash Equivalents	$102,613,568	$75,019,268	$194,795,045	$593,386,654
Cash Financial	$102,613,568	$75,019,268	$83,852,620	$534,995,904
Cash Equivalents	-	$0	$110,942,425	$58,390,750
Financial Assets Designatedas Fair Value Through Profitor Loss Total	-	-	$15,853,089	$0
Other Current Assets	-	-	-	$2,336
Debt
Total Debt	$8,075,441	$13,689,127	$11,206,353	$25,576,316
Long Term Debt And Capital Lease Obligation	$6,056,289	$9,626,299	$5,773,677	$17,157,538
Current Debt And Capital Lease Obligation	$2,019,152	$4,062,828	$5,432,675	$8,418,778
Liabilities
Total Liabilities Net Minority Interest	$199,287,630	$1,446,665,866	$1,823,928,501	$2,578,915,060
Total Non Current Liabilities Net Minority Interest	$20,771,925	$1,055,353,248	$1,323,843,259	$1,968,687,345
Other Non Current Liabilities	$14,715,637	$39,496,671	$36,867,920	$25,467,710
Non Current Deferred Liabilities	$0	$1,003,779,034	$1,278,523,862	$1,919,592,403
Non Current Deferred Taxes Liabilities	$0	$24,127,058	$27,568,609	$23,529,137
Current Liabilities	$178,515,704	$391,312,618	$500,085,243	$610,227,714
Other Current Liabilities	$45,428,004	$39,186,032	$37,421,464	$9,932,267
Current Deferred Liabilities	$37,370	$271,488,960	$299,275,950	$426,989,366
Payables And Accrued Expenses	$39,235,081	$76,574,797	$157,955,153	$164,887,303
Payables	$39,211,724	$75,299,543	$157,315,191	$164,127,056
Total Tax Payable	$1,116,431	$290,786	$65,398	$1,193,507
Accounts Payable	$38,095,293	$75,008,757	$157,249,793	$155,667,404
Other Payable	-	-	-	$7,266,145
Equity
Common Stock Equity	$3,778,895,188	$3,383,088,818	$3,264,703,908	$2,949,931,053
Total Equity Gross Minority Interest	$3,778,895,188	$3,383,088,818	$3,264,703,908	$2,949,931,053
Stockholders Equity	$3,778,895,188	$3,383,088,818	$3,264,703,908	$2,949,931,053
Gains Losses Not Affecting Retained Earnings	$-6,586,477	$366,694	$-8,280,976	$-7,527,735
Other Equity Adjustments	$-10,086,418	$-3,687,960	$-6,878,430	$-5,667,406
Retained Earnings	$245,914,979	$-156,844,561	$-266,581,801	$-580,040,865
Long Term Equity Investment	$54,664,252	$61,825,294	$15,853,089	-
Other
Ordinary Shares Number	$76,955,588	$76,955,588	$76,955,588	$76,883,697
Share Issued	$76,955,588	$76,955,588	$76,955,588	$76,883,697
Tangible Book Value	$3,777,904,881	$3,108,801,774	$3,034,103,655	$2,697,489,156
Invested Capital	$3,778,895,188	$3,383,088,818	$3,264,703,908	$2,949,931,053
Working Capital	$3,417,720,372	$3,508,547,184	$4,009,536,315	$4,337,629,268
Capital Lease Obligations	$8,075,441	$13,689,127	$11,206,353	$25,576,316
Total Capitalization	$3,778,895,188	$3,383,088,818	$3,264,703,908	$2,949,931,053
Foreign Currency Translation Adjustments	$3,499,942	$4,054,654	$-1,402,546	$-1,860,329
Additional Paid In Capital	$3,196,302,648	$3,196,302,648	$3,196,302,648	$3,194,624,498
Capital Stock	$343,264,038	$343,264,038	$343,264,038	$342,875,155
Common Stock	$343,264,038	$343,264,038	$343,264,038	$342,875,155
Employee Benefits	$0	$2,451,244	$2,677,800	$6,469,695
Non Current Pension And Other Postretirement Benefit Plans	$0	$2,451,244	$2,677,800	$6,469,695
Non Current Deferred Revenue	$0	$979,651,976	$1,250,955,253	$1,896,063,266
Long Term Capital Lease Obligation	$6,056,289	$9,626,299	$5,773,677	$17,157,538
Current Deferred Revenue	$37,370	$271,488,960	$299,275,950	$426,989,366
Current Capital Lease Obligation	$2,019,152	$4,062,828	$5,432,675	$8,418,778
Pensionand Other Post Retirement Benefit Plans Current	$38,661,683	$0	-	-
Current Provisions	$53,134,415	-	-	-
Current Accrued Expenses	$23,356	$1,275,254	$639,963	$760,248
Investments And Advances	$54,664,252	$295,600,836	$15,853,089	$0
Goodwill	$0	$81,758,728	$81,229,708	$81,528,669
Net PPE	$94,198,294	$143,522,128	$147,519,559	$180,138,967
Accumulated Depreciation	$-69,623,962	$-61,954,921	$-59,864,533	$-71,365,175
Gross PPE	$163,822,256	$205,477,049	$207,384,091	$251,504,142
Leases	$16,575,966	$28,710,732	$27,062,945	$40,679,668
Other Properties	$3,713,652	$10,049,048	$17,135,349	$28,645,334
Machinery Furniture Equipment	$44,281,209	$66,268,830	$57,259,137	$78,571,761
Land And Improvements	$99,251,429	$100,448,439	$105,926,660	$103,607,379
Properties	$0	$0	$0	$0
Raw Materials	$26,267,663	$59,782,785	$64,536,960	$45,627,700
Other Short Term Investments	$3,398,551,857	$3,565,729,245	$4,108,020,490	$4,187,720,360
Finished Goods	-	$0	$7,143,524	$9,416,092
Work In Process	-	$0	$14,712,133	$6,762,817

Fetched: 2026-08-23

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-316,845,727	$-469,620,453	$-496,605,154	$-627,690,052
Operating Activities
Operating Cash Flow	$-300,660,979	$-373,731,163	$-474,097,856	$-584,542,791
Cash Flow From Continuing Operating Activities	$-300,660,979	$-373,731,163	$-474,099,023	$-584,542,791
Operating Gains Losses	$20,648,137	$-89,149,829	$21,966,600	$-49,098,446
Investing Activities
Capital Expenditure	$-16,184,748	$-95,889,290	$-22,507,298	$-43,147,261
Investing Cash Flow	$337,281,321	$257,616,486	$83,132,079	$-1,454,529,932
Cash Flow From Continuing Investing Activities	$337,281,321	$257,616,486	$83,132,079	$-1,454,529,932
Net Other Investing Changes	$-23,356,300	-	-	$-11,678,150
Financing Activities
Financing Cash Flow	$-3,822,258	$-5,750,321	$-5,840,243	$-1,736,541
Cash Flow From Continuing Financing Activities	$-3,822,258	$-5,750,321	$-5,840,243	$-1,736,541
Net Other Financing Charges	-	-	$2,067,033	$7,818,521
Issuance Of Capital Stock	-	-	-	-
Net Common Stock Issuance	-	-	-	-
Common Stock Issuance	-	-	-	-
Other
Repayment Of Debt	$-3,822,258	$-5,750,321	$-7,907,275	$-9,555,062
End Cash Position	$102,613,568	$75,019,268	$194,803,220	$593,386,654
Beginning Cash Position	$75,019,268	$194,803,220	$593,386,654	$2,608,160,651
Effect Of Exchange Rate Changes	$-5,203,784	$2,081,046	$-1,777,414	$26,034,100
Changes In Cash	$32,798,084	$-121,864,999	$-396,806,020	$-2,040,808,096
Net Issuance Payments Of Debt	$-3,822,258	$-5,750,321	$-7,907,275	$-9,555,062
Net Long Term Debt Issuance	$-3,822,258	$-5,750,321	$-7,907,275	$-9,555,062
Long Term Debt Payments	$-3,822,258	$-5,750,321	$-7,907,275	$-9,555,062
Interest Received Cfi	$70,592,081	$34,448,207	$17,242,788	$3,498,774
Net Investment Purchase And Sale	$282,998,945	$329,504,841	$93,738,174	$-1,269,452,275
Sale Of Investment	$4,329,543,317	$4,284,060,426	$4,069,147,432	$1,917,087,440
Purchase Of Investment	$-4,046,544,373	$-3,954,555,585	$-3,975,409,258	$-3,186,539,715
Net Business Purchase And Sale	$22,691,813	$-10,450,776	$-8,174,705	$-134,614,035
Sale Of Business	$22,691,813	-	$0	$0
Purchase Of Business	$0	$-10,450,776	$-8,174,705	$-134,614,035
Net Intangibles Purchase And Sale	$-181,011	$-76,363,423	$-662,151	$-11,161,976
Purchase Of Intangibles	$-181,011	$-76,363,423	$-662,151	$-11,161,976
Net PPE Purchase And Sale	$-15,464,206	$-19,522,363	$-19,012,028	$-31,122,270
Sale Of PPE	$539,531	$3,503	$2,833,119	$863,015
Purchase Of PPE	$-16,003,737	$-19,525,867	$-21,845,147	$-31,985,285
Taxes Refund Paid	$-434,427	$474,133	$-9,541,049	$-5,176,924
Interest Received Cfo	$59,886,721	$113,882,983	$81,638,443	$5,651,057
Interest Paid Cfo	$-541,866	$-804,625	$-4,448,207	$-14,554,478
Change In Working Capital	$-1,023,669,259	$-374,344,266	$-808,635,980	$-443,149,590
Change In Other Working Capital	$-1,197,967,983	$-298,386,075	$-771,998,120	$-447,994,855
Change In Other Current Liabilities	$39,487,329	$-66,596,986	$37,156,370	$-35,322,900
Change In Inventory	$33,692,631	$26,905,290	$-28,116,314	$-40,392,385
Change In Receivables	$101,118,765	$-36,266,495	$-45,677,916	$80,560,550
Other Non Cash Items	$-117,761,297	$-137,559,264	$-107,110,824	$1,201,682
Stock Based Compensation	$28,026,392	$23,223,169	$66,236,131	$103,358,634
Unrealized Gain Loss On Investment Securities	$59,250,262	$-58,372,065	$-26,042,274	$-8,091,790
Asset Impairment Charge	$255,131,375	$11,261,240	$0	$0
Deferred Tax	$-21,181,828	$-1,991,125	$13,650,590	$3,321,266
Deferred Income Tax	$-21,181,828	$-1,991,125	$13,650,590	$3,321,266
Depreciation Amortization Depletion	$65,251,663	$53,134,415	$50,965,782	$76,568,958
Depreciation And Amortization	$65,251,663	$53,134,415	$50,965,782	$76,568,958
Depreciation	$65,251,663	$53,134,415	$50,965,782	$76,568,958
Pension And Employee Benefit Expense	$-2,746,701	$-611,935	$12,846	$158,823
Gain Loss On Investment Securities	$-26,561,952	$-4,671	$-21,021	$-217,214
Net Foreign Currency Exchange Gain Loss	$51,192,338	$-27,861,730	$23,248,861	$-49,013,196
Gain Loss On Sale Of PPE	$31,531	$9,343	$-1,274,086	$-26,860
Gain Loss On Sale Of Business	$-1,267,079	$-60,680,835	$0	$0
Net Income From Continuing Operations	$374,733,148	$86,514,071	$247,222,932	$-254,573,160
Other Cash Adjustment Outside Changein Cash	-	-	-	-
Proceeds From Stock Option Exercised	-	-	-	-

Fetched: 2026-08-23